Quantinno Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Quantinno Capital Management's VRTX Position: Q2 2026 in Review
Quantinno Capital Management increased its Vertex Pharmaceuticals (VRTX) stake by 29% in Q2 2026, buying an estimated $16.2M and bringing the position to 163,085 shares worth $81M. The position accounts for 0.1% of the portfolio, ranked #231.
Quantinno Capital Management first reported a position in VRTX in Q2 2022 and has held it in 17 quarters since. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Quantinno Capital Management held 163,085 shares of Vertex Pharmaceuticals worth $81M as of Q2 2026.
- Quantinno Capital Management bought 36,481 Vertex Pharmaceuticals shares in Q2 2026, an estimated $16.2M.
- Vertex Pharmaceuticals made up 0.1% of Quantinno Capital Management's portfolio in Q2 2026, its #231 holding.
- Quantinno Capital Management first reported a position in Vertex Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
- 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.